Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP419740.RAYdHMA41qZPj1pcthiLGiYq1ZPyl_pC3td7djcAl912o130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP419740.RAYdHMA41qZPj1pcthiLGiYq1ZPyl_pC3td7djcAl912o130_assertion type Assertion NP419740.RAYdHMA41qZPj1pcthiLGiYq1ZPyl_pC3td7djcAl912o130_head.
- NP419740.RAYdHMA41qZPj1pcthiLGiYq1ZPyl_pC3td7djcAl912o130_assertion description "[When 293-Flt1-3d cells were inoculated at a site remote to the FTC-133 tumor transplant, the growth of FTC-133 tumors were inhibited by 70.37%, as compared with the control treatment with 293 cells expressing control gene LacZ.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419740.RAYdHMA41qZPj1pcthiLGiYq1ZPyl_pC3td7djcAl912o130_provenance.
- NP419740.RAYdHMA41qZPj1pcthiLGiYq1ZPyl_pC3td7djcAl912o130_assertion evidence source_evidence_literature NP419740.RAYdHMA41qZPj1pcthiLGiYq1ZPyl_pC3td7djcAl912o130_provenance.
- NP419740.RAYdHMA41qZPj1pcthiLGiYq1ZPyl_pC3td7djcAl912o130_assertion SIO_000772 14605010 NP419740.RAYdHMA41qZPj1pcthiLGiYq1ZPyl_pC3td7djcAl912o130_provenance.
- NP419740.RAYdHMA41qZPj1pcthiLGiYq1ZPyl_pC3td7djcAl912o130_assertion wasDerivedFrom befree-2016 NP419740.RAYdHMA41qZPj1pcthiLGiYq1ZPyl_pC3td7djcAl912o130_provenance.
- NP419740.RAYdHMA41qZPj1pcthiLGiYq1ZPyl_pC3td7djcAl912o130_assertion wasGeneratedBy ECO_0000203 NP419740.RAYdHMA41qZPj1pcthiLGiYq1ZPyl_pC3td7djcAl912o130_provenance.